Chandler D. Robinson owns 2.49% of Monopar Therapeutics
166,942 shares as of the October 20, 2026 filing, worth $11.8M at the latest close.
MNPR · $473M market cap · Founder-ledGet an email when Chandler D. Robinson’s stake moves.
Free.
The stake
2.49%
worth $11.8M at the latest close
Stake rank
#1,614
by dollar value of the stake
Last sale
398 days ago
Sep 24, 2025
Last buy
2,505 days ago
Dec 18, 2019 · $1M
Chandler D. Robinson owns 2.49% of Monopar Therapeutics: 166,942 of 6,712,172 shares, worth about $11.8M at the 2026-10-26 close. The stake has moved from 47.84% in 2018 to 2.49% on 2026-10-20, across 3 sales and 1 purchase that moved it since 2016. The last trade that moved it was a discretionary sale of $35M on 2025-09-24.
How the stake is held
as of the Oct 20, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Oct 20, 2026 · Form 4 ↗
HELD DIRECTLY
104,127
62.4%
HELD INDIRECTLY · Indirect, per the filing’s footnote
62,815
37.6%
THE STAKE
166,942
2.49%
Keep reading